MOEA Leads Taiwan Pharma Pavilion at CPHI Japan and ITRI Partners with iPark Institute to Target the Asia-Pacific Pharmaceutical Market

CPHI Japan, a leading global pharmaceutical exhibition, opened on April 21. Led by the Department of Industrial Technology (DoIT) under the Ministry of Economic Affairs (MOEA), 16 leading biomedical companies formed the Taiwan Pharma Pavilion to expand their presence in the Asia-Pacific market. During the opening ceremony, Chien-Cheng Tai, Senior Specialist at DoIT, noted that 2026 marks a pivotal year for Taiwan's pharmaceutical industry as it expands beyond its R&D strengths to build a more complete global supply chain presence. As part of this effort, the MOEA is promoting a